DrugPatentWatch Database Preview

Drugs in Development Information for Tivantinib

US Patents	17
International Patents	133
US Patent Applications	33
WIPO Patent Applications	14
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2010-11-01)
Vendors	47

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Tivantinib	➤ Sign Up	Compositions and methods for treatment of cancer	ArQule, Inc. (Woburn, MA)	➤ Sign Up
Tivantinib	➤ Sign Up	Kinase inhibition models and their uses	ArQule, Inc. (Woburn, MA)	➤ Sign Up
Tivantinib	➤ Sign Up	Kinase inhibition models and their uses	ArQule, Inc. (Woburn, MA)	➤ Sign Up
Tivantinib	➤ Sign Up	Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer	ArQule, Inc. (Woburn, MA)	➤ Sign Up
Tivantinib	➤ Sign Up	Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds	ArQule, Inc. (Woburn, MA)	➤ Sign Up
Tivantinib	➤ Sign Up	Compositions and methods for treatment of cancer	ArQule, Inc. (Woburn, MA)	➤ Sign Up
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Tivantinib	Austria	486872	2025-02-09	➤ Sign Up
Tivantinib	Australia	2006213890	2025-02-09	➤ Sign Up
Tivantinib	Brazil	PI0607240	2025-02-09	➤ Sign Up
Tivantinib	Canada	2599611	2025-02-09	➤ Sign Up
Tivantinib	China	101133055	2025-02-09	➤ Sign Up
Tivantinib	China	101941970	2025-02-09	➤ Sign Up
Drugname	Country	Document Number	Estimated Expiration	Related US Patent